Alan Stewart Maisel

Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA.

Scios Inc. developed, manufactured, and commercialized pharmaceuticals for conditions such as cardiovascular and inflammatory diseases. The company was founded in 1981 and was headquartered in Sunnyvale, CA.

DUSA Pharmaceuticals, Inc. is an integrated dermatology pharmaceutical company, which develops and markets Levulan Photodynamic Therapy technology platform for the prevention and treatment of dermatological skin conditions. Its products include levulan kerastick, BLU-U and clindareach. The company was founded by D. Geoffrey Shulman on February 21, 1991 and is headquartered in Wilmington, MA.

Cowen & Co. LLC is a SEC-registered broker/dealer headquartered in New York City. The firm was founded in 2004 and is a subsidiary of Cowen Holdings, Inc., ultimately owned by The Toronto-Dominion Bank (TSE: TD) in Canada. Cowen & Co. offers industry-focused investment banking for growth-oriented companies, domain knowledge-driven research and a sales and trading platform for institutional investors. Their institutional sales and trading business serves both equity and fixed-income clients. Sales and trading execution platform is structured around the following key verticals: (1) healthcare (2) technology, telecommunications and media (TMT) (3) REITs and financials (4) aerospace and defense (5) consumer and (6) alternative energy.

Metabasis Therapeutics, Inc. engages in discovery, development and commercialization of novel drugs for metabolic diseases using the proprietary technology and the knowledge of processes and pathways within the liver that are useful for liver-selective drug targeting and treatment of metabolic diseases. Metabasis was incorporated in April 1997 and is headquartered in La Jolla, CA.

Jazz Pharmaceuticals, Inc. develops and markets pharmaceutical products. Its medical products include xyrem, erwinaze, vyxeos, and kidrolas. The company was founded by Bruce C. Cozadd in 2003 and is headquartered in Palo Alto, CA.

Raven Biotechnologies, Inc. engages in the development of antibody therapeutics for the treatment for cancer, autoimmune disorders and infectious diseases. Its products are used in treatment of gastrointestinal, lung, colon, pancreatic, prostate, breast, brain, and ovarian cancer. The company was founded in 1999 and is headquartered in South San Francisco, CA.

Cornell University is an educational institution that offers undergraduate and post graduate programs. It was founded in 1865 and is based in Ithaca, NY.

Whitney Museum of American Art exhibits or sells artwork. The museum was founded by Gertrude Vanderbilt Whitney in 1930 and is headquartered in New York, NY.

Johnson & Johnson Pvt. Ltd. manufactures healthcare products. The firm operates through the following business segments: Consumer, Pharmaceutical and Medical Devices. The company was incorporated on September 05, 1957 and is headquartered in Mumbai, India.

Mountain Group Capital LLC (Mountain Group Capital) is a venture capital investment firm founded in 2002. The firm is headquartered in Nashville, Tennessee.

Schering-Plough Research Institute provides pharmaceutical research. The company is headquartered in Kenilworth, NJ.

Embark Healthcare (Embark Healthcare) is a ventures capital firm founded in 2001 by David M Geliebter. The firm is headquartered in New York.

SAI Life Sciences Ltd. manufactures, develops, and discovers pharmaceutical drugs. The company was founded in 1999 and is headquartered in Hyderabad, India.

Ipsen, Inc. design and manufacture of industrial atmosphere and vacuum heat-treating systems and supervisory controls systems. It offers vacuum furnaces, atmosphere furnaces, and PdMetrics software platform. The company was founded by Harold Ipsen in 1948 and is headquartered in Cherry Valley, IL.

Sphaera Pharma Pvt Ltd. discovers and develops pharmaceutical drugs. The firm’s services include services such as in radio-chemistry, c-GMP manufacture, GLP studies, clinical formulations, structural biology and clinical development. The company was founded in 2008 and is headquartered in Gurgaon, India.

Mubadala Capital (Mubadala Capital) is a private equity subsidiary of Mubadala Investment Co. PJSC founded in 2011. The firm is headquartered in Abu Dhabi, United Arab Emirates with offices in London, New York, Rio De Janeiro, and San Francisco.

Conquer Cancer Foundation of the American Society of Clinical Oncology operates as a non-profit organization that researches in the prevention, treatment, and cure of cancer. Its programs include health information technology platform; patient resources; online medical education; and meetings, symposia, and workshop. The company was founded in 1964 and is headquartered in Alexandria, VA.

Vascular Cures is a voluntary health organization that operates to improve the lives of individuals affected by vascular diseases. Vascular Cures is based in Redwood City, CA. The non-profit company's focus is on advancing research, education, and awareness of vascular diseases. The CEO of the company is Wendy R. Hitchcock.

Reneo Capital Management LP provides investment advice. The private company is based in New York, NY and has subsidiaries in the United States. Alexander Whitman Casdin has been the CEO of the company since 2013.

Ternus Pharma, Inc. operates as a biotechnology company. It develops enhanced general anesthetic. The company is headquartered in Duxbury, MA.

RA Capital Management LP (Private Equity) (RA Capital) is a private equity & venture capital subsidiary of RA Capital Management LP founded by Peter Kolchinsky in 2004. The firm is headquartered in Boston, MA.

Elephas Biosciences Corp. is a live tumor imaging company that provides cancer diagnostic solutions to predict treatment outcomes and accelerate drug development. The company is based in Madison, WI and was founded by Maneesh K. Arora, who has been the CEO since incorporation. The company's revolutionary diagnostic platform brings insights to cancer treatment decisions and accelerates immuno-oncology drug development. Investors can learn about clinical trials aimed at predicting responses to immunotherapy and how immunotherapeutic drug development can be accelerated with Elephas Biosciences's cybrid.

Areteia Therapeutics, Inc. is a clinical stage biotechnology company that focuses on developing and delivering novel inflammation and immunology therapies for respiratory patients. The company is based in Short Hills, NJ, and the CEO of the company is Jorge Bartolome. The company's initial focus is on developing the first potential oral drug for eosinophilic asthma, with its lead drug candidate being dexpramipexole, a first-in-class oral eosinophil maturation inhibitor. Areteia was created by Population Health Partners and Knopp Biosciences, and a syndicate of leading life sciences and strategic investors has committed to investing up to $350 million in series A financing to establish Areteia and advance dexpramipexole through phase III clinical trials.

Human Immunology Biosciences, Inc. is a company based in South San Francisco, CA. Human Immunology Biosciences, Inc. was founded by Travis Murdoch, who has been the CEO since incorporation.